1. Home
  2. PEN vs JNPR Comparison

PEN vs JNPR Comparison

Compare PEN & JNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • JNPR
  • Stock Information
  • Founded
  • PEN 2004
  • JNPR 1996
  • Country
  • PEN United States
  • JNPR United States
  • Employees
  • PEN N/A
  • JNPR N/A
  • Industry
  • PEN Medical/Dental Instruments
  • JNPR Computer Communications Equipment
  • Sector
  • PEN Health Care
  • JNPR Telecommunications
  • Exchange
  • PEN Nasdaq
  • JNPR Nasdaq
  • Market Cap
  • PEN 10.0B
  • JNPR 11.3B
  • IPO Year
  • PEN 2015
  • JNPR 1999
  • Fundamental
  • Price
  • PEN $291.61
  • JNPR $36.00
  • Analyst Decision
  • PEN Buy
  • JNPR Buy
  • Analyst Count
  • PEN 16
  • JNPR 6
  • Target Price
  • PEN $287.07
  • JNPR $39.80
  • AVG Volume (30 Days)
  • PEN 509.6K
  • JNPR 5.8M
  • Earning Date
  • PEN 02-18-2025
  • JNPR 02-04-2025
  • Dividend Yield
  • PEN N/A
  • JNPR 2.47%
  • EPS Growth
  • PEN N/A
  • JNPR N/A
  • EPS
  • PEN 0.36
  • JNPR 0.86
  • Revenue
  • PEN $1,194,615,000.00
  • JNPR $5,073,600,000.00
  • Revenue This Year
  • PEN $13.65
  • JNPR $8.21
  • Revenue Next Year
  • PEN $14.30
  • JNPR $1.57
  • P/E Ratio
  • PEN $811.72
  • JNPR $41.49
  • Revenue Growth
  • PEN 12.86
  • JNPR N/A
  • 52 Week Low
  • PEN $148.00
  • JNPR $33.72
  • 52 Week High
  • PEN $310.00
  • JNPR $39.79
  • Technical
  • Relative Strength Index (RSI)
  • PEN 65.03
  • JNPR 43.19
  • Support Level
  • PEN $264.82
  • JNPR $35.86
  • Resistance Level
  • PEN $310.00
  • JNPR $36.88
  • Average True Range (ATR)
  • PEN 7.93
  • JNPR 0.52
  • MACD
  • PEN 2.79
  • JNPR 0.06
  • Stochastic Oscillator
  • PEN 64.07
  • JNPR 64.60

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

About JNPR Juniper Networks Inc.

Juniper Networks Inc is engaged in designing, developing, and selling products and services for high-performance networks to enable customers to build scalable, reliable, secure, and cost-effective networks for their businesses while achieving agility and improved operating efficiency through automation. The company's high-performance network and service offerings include routing, switching, Wi-Fi, network security, artificial intelligence (AI) or AI-enabled enterprise networking operations (AIOps), and software-defined networking (SDN) technologies. In addition to the company's products, the company offers its customers a variety of services, including maintenance and support, professional services, Software-as-a-Service ("SaaS"), and education and training programs.

Share on Social Networks: